STA Satellite Automated Multi-Parameter Analyzer This system is a fully automatic clinical instrument indicated and intended for the performance of tests on human plasma, the results of which aid in the diagnosis of coagulation abnormalities or in monitoring anticoagulant therapy.
Published November 14, 2012 · Recall initiated: June 15, 2012
Summary
FDA records medical device Class II recall Z-0252-2013, published November 14, 2012 and initiated June 15, 2012. Recalling firm: Diagnostica Stago, Inc.; Status: Terminated; Reported quantity: 232 units US; 5 units Canada; Lot: K082248 D089976 Ref 58104 units. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Following a single customer complaint that incorrect INR values were occasionally printed for PT tests, even though the primary units (seconds) were correct, the firm investigated and confirmed the potential for printing incorrect secondary units when using an external printer and the customer printout mode on the STA Satellite®.
What to do
Voluntary: Firm initiated · E-Mail
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Diagnostica Stago, Inc.
- Distributor
- Worldwide Distribution - USA (nationwide) and Canada
- Lot
- K082248 D089976 Ref 58104 units
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDASTA Staclot Protein S, Model/Catalog Number: 00746-Reagent Lot number 273074; qualitative and quantitativeSeptember 9, 2026
- FDASTA-Liquid Anti-Xa 4. Model/Catalog Number: 00311US. The STA - Liquid Anti-Xa kits are intended for use withSeptember 3, 2025
- FDADiagnostica Stago STA N®oplastine® CI, 10 ml vial. In-Vitro Diagnostic for determination of the prothrombinSeptember 19, 2018
- FDANeoplastine® Cl Plus @ (ref.00374) Product Usage: Manual or automated determination of the prothrombin timeMarch 21, 2018
- FDASunquest Application Interfacing Outbound Phlebotomy Point of Care Interface, v3.0.0_07222004 and later.November 14, 2012
- FDASiemens Dimension Vista(R) Homocysteine Flex(R) Reagent Cartridge This is an in vitro diagnostic test for theNovember 14, 2012
Questions about this recall
Was STA Satellite Automated Multi-Parameter Analyzer This system is a fully automatic clinical instrument indicated and intended for the performance of tests on human plasma, the results of which aid in the diagnosis of coagulation abnormalities or in monitoring anticoagulant therapy. recalled?
Yes. FDA published recall Z-0252-2013 on November 14, 2012. Reported hazard: Following a single customer complaint that incorrect INR values were occasionally printed for PT tests, even though the primary units (seconds) were correct, the firm investigated and confirmed the potential for printing incorrect secondary units when using an external printer and the customer printout mode on the STA Satellite®.
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail